Showing results (181-190 of 203) with videos related to

Sort By:
Pageof 21
Current Oncology (Toronto, Ont.)|January 5, 2019
Reducing postsurgical exudate in breast cancer patients by using San Huang decoction to ameliorate inflammatory status: a prospective clinical trialZ Y Zhu, J X Xue, L X Yu, et al.
Breast Cancer Research and Treatment|October 17, 2016
Changes in chemotherapy usage and outcome of early breast cancer patients in the last decadeA Hennigs, F Riedel, F Marmé, et al.
Blood|April 1, 1986
Leukopenic chronic T cell leukemia mimicking hairy cell leukemia: association with human retrovirusesC C Sohn, D W Blayney, J L Misset, et al.
HNO|January 16, 2009
[Universal newborn hearing screening. Methodical aspects]S Hoth, K Neumann, H Weissschuh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2009
Phase I study of apoptosis gene modulation with oblimersen within preoperative chemotherapy in patients with primary breast cancerJ Rom, G von Minckwitz, F Marmé, et al.
Archives of Gynecology and Obstetrics|January 5, 2019
The impact of a cervical dysplasia diagnosis on individual cancer prevention habits over time: a bicentric case-control studyN Rippinger, J Heinzler, T Bruckner, et al.
Gynecologic Oncology|May 23, 2017
Pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant, recurrent, pre-treated ovarian cancer - Results of the PACOVAR-trialC Dinkic, M Eichbaum, M Schmidt, et al.
Annals of Surgical Oncology|October 16, 2015
Can Routine Imaging After Neoadjuvant Chemotherapy in Breast Cancer Predict Pathologic Complete Response?B Schaefgen, M Mati, H P Sinn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 2008
Oblimersen combined with docetaxel, adriamycin and cyclophosphamide as neo-adjuvant systemic treatment in primary breast cancer: final results of a multicentric phase I studyJ Rom, G von Minckwitz, W Eiermann, et al.
The Journal of Investigative Dermatology|July 6, 2012
Epigallocatechin-3-gallate suppresses IGF-I-induced lipogenesis and cytokine expression in SZ95 sebocytesMyung Im, Soo Y Kim, Kyung C Sohn, et al.
Pageof 21